| Transcode Therapeutics, Inc. (RNAZ) |
| Q2-CY2026 | Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 |
| Balance Sheet Date | | | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Jun-30 | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Fiscal Period | | | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Common Stock | 9.94$ | 8.55$ | 6.65$ | 10.32$ | 8.10$ | 0.49$ | 3.40$ | 0.57$ | 0.96$ | 0.65$ | 0.17$ | 0.50$ | 2.27$ | 0.32$ | 0.65$ | 1.21$ | 1.29$ | 2.65$ | 2.53$ | 3.00$ | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Market Cap of Common Stock | 9,114,662$ | 7,840,076$ | 6,093,252$ | 8,599,440$ | 189,064,822$ | 8,529,235$ | 58,703,237$ | 9,882,863$ | 6,357,833$ | 13,103,633$ | 3,318,113$ | 1,012,837$ | 38,586,672$ | 4,163,097$ | 8,405,354$ | 15,637,567$ | 16,740,632$ | 34,197,121$ | 32,648,572$ | 38,713,722$ | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| QoQ% | 16.26% | 28.67% | (29.14%) | (95.45%) | 2,116.67% | (85.47%) | 493.99% | 55.44% | (51.48%) | 294.91% | 227.61% | (97.38%) | 826.87% | (50.47%) | (46.25%) | (6.59%) | (51.05%) | 4.74% | (15.67%) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| YoY% | (95.18%) | (8.08%) | (89.62%) | (12.99%) | 2,873.73% | (34.91%) | 1,669.18% | 875.76% | (83.52%) | 214.76% | (60.52%) | (93.52%) | 130.50% | (87.83%) | (74.26%) | (59.61%) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Warrant | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Unit | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Right | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Common Shares Outstanding | 916,968 | | 916,968 | 833,683 | 833,683 | 23,341,336 | 36,753 | 17,265,658 | 7,265,658 | 5,808,053 | 19,014 | 10,687,724 | 1,950,674 | 15,823,534 | 16,222 | 12,977,234 | 12,977,234 | 12,977,234 | 12,904,574 | 12,904,574 | 4,636,216 | 4,636,216 | 4,636,216 | 4,636,216 | 4,636,216 | | | | | | | | | | | | | | | | | | | | | | | | |
| QoQ% | | | 9.99% | .00% | (96.43%) | 63,408.66% | (99.79%) | 137.63% | 25.10% | 30,446.19% | (99.82%) | 447.90% | (87.67%) | 97,443.67% | (99.88%) | .00% | .00% | .56% | .00% | 178.34% | .00% | .00% | .00% | .00% | | | | | | | | | | | | | | | | | | | | | | | | | |
| YoY% | 9.99% | | 2,394.95% | (95.17%) | (88.53%) | 301.88% | 93.29% | 61.55% | 272.47% | (63.30%) | 17.21% | (17.64%) | (84.97%) | 21.93% | (99.87%) | .56% | 179.91% | 179.91% | 178.34% | 178.34% | .00% | | | | | | | | | | | | | | | | | | | | | | | | | | | | |